Everolimus &Ndash; A New Approach in the Treatment of Renal Cell Carcinoma

Cancer Management and Research - New Zealand
doi 10.2147/cmr.s6047
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Dove Medical Press Ltd.

Related search

Re: Nivolumab Versus Everolimus in Advanced Renal-Cell Carcinoma

European Urology
Urology
2016English

New Systemic Approaches in the Treatment of Metastatic Renal Cell Carcinoma

2012English

Current Treatment Approach to Non-Clear Cell Renal Carcinoma

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2015English

A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research
MedicineForensic MedicinePathologyOncologyCancer Research
2020English

Clinical Experience and Critical Evaluation of the Role of Everolimus in Advanced Renal Cell Carcinoma

Research and Reports in Urology
Urology
2011English

Everolimus in Metastatic Renal Cell Carcinoma : Preliminary Experience From Chang Gung Memorial Hospital

Biomedical Journal
Medicine
2012English

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy